Guidance

Reporting adverse incidents: breast implants

For manufacturers reporting adverse incidents with breast implants under the European vigilance system.

From:
Medicines and Healthcare products Regulatory Agency
Published
1 October 2009

This publication was withdrawn on

Withdrawn due to the end of the Brexit transition period. Please see https://ec.europa.eu/docsroom/documents/37284

Documents

Adverse incidents with breast implants

PDF, 78 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Guidance on how and when to report adverse incidents with breast implants. You need to read this alongside the European Commission’s guidelines on the vigilance system for medical devices.

Updates to this page

Published 1 October 2009

Sign up for emails or print this page

Related content